L
Description
Clinical-stage life sciences company founded in 2019 in Concord, Massachusetts, specialized in the creative application of deuterium chemistry to improve metabolic and pharmacological profiles of existing drugs, with deuterated candidates of psilocybin, caffeine and testosterone.